Global HMO Children's Formula Milk Powder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global HMO Children's Formula Milk Powder market size was valued at US$ 4013 million in 2024 and is forecast to a readjusted size of USD 7971 million by 2031 with a CAGR of 10.7% during review period.
HMO (Human Milk Oligosaccharides) Children’s Formula Milk Powder is an advanced infant formula designed to mimic the composition of breast milk as closely as possible, providing essential nutrients for babies’ growth and development. HMOs are complex carbohydrates that are naturally found in human breast milk and are critical for promoting a healthy gut microbiome, enhancing immune function, and supporting cognitive development. HMO-based formulas are an innovation that brings the benefits of breast milk oligosaccharides to babies who are not breastfed, helping to address nutritional gaps and support their overall health.
HMO formula milk powder contains a blend of different HMOs, such as 2'-FL (2'-fucosyllactose), which is the most abundant HMO in human milk. These oligosaccharides are beneficial in promoting the growth of beneficial gut bacteria, which is important for babies’ digestive health. In addition to HMOs, the formula is enriched with other key nutrients like proteins, fats, carbohydrates, vitamins, and minerals, which are essential for babies’ optimal growth during their early developmental stages.
The product range of HMO Children’s Formula Milk Powder is usually categorized based on the baby’s age and nutritional needs. There are typically different stages of formula milk, such as Stage 1 (newborn to 6 months), Stage 2 (6 months to 12 months), and Stage 3 (1 year and above). Each stage is carefully designed to match the developmental needs of babies at different ages, with the appropriate ratio of proteins, fats, and carbohydrates, alongside the inclusion of HMOs for immune and digestive health support.
Some formulas are also designed for specific dietary needs, such as lactose-free, soy-based, or hypoallergenic formulas, offering solutions for babies with sensitivities or allergies. The addition of HMOs in these specialized formulas further enhances their ability to mimic the benefits of breast milk and provide a more tailored approach to infant nutrition.
The market for HMO Children’s Formula Milk Powder has witnessed significant growth due to several key drivers. First and foremost, the increasing awareness among parents about the benefits of HMO in supporting babies’ immune and gut health has contributed to the demand for HMO-based formulas. Many parents are seeking alternatives to breast milk that provide similar health benefits, particularly for babies who cannot be breastfed due to medical or personal reasons.
Additionally, the global trend of delayed motherhood and the rising number of working mothers have created a higher demand for infant formula, including HMO-based products. HMO formula provides a convenient and nutritionally balanced option for mothers who cannot breastfeed, helping to alleviate concerns about the nutritional intake of their babies.
Technological advancements in the production and formulation of HMO milk powder have also created opportunities for market growth. Manufacturers are investing in research and development to improve the quality, affordability, and availability of HMO-based formulas. Advances in biotechnological processes, such as the fermentation of specific oligosaccharides, have made it possible to incorporate HMOs into infant formula in a cost-effective manner.
Market Risks:
Despite the positive growth prospects, the market for HMO Children’s Formula Milk Powder faces several risks. Regulatory challenges are one of the main risks, as governments in various regions impose strict regulations and safety standards on infant formula products. These regulations may vary across different markets, creating barriers for manufacturers seeking to enter new regions or expand their product offerings.
Price sensitivity is another challenge, as HMO formulas are often more expensive than regular infant formulas due to the complex production process involved in extracting and incorporating HMOs. This could limit the growth of the HMO formula market in lower-income regions or among price-conscious consumers.
Additionally, there are concerns about the long-term health implications of feeding babies formula-based nutrition instead of breast milk. Some parents and healthcare professionals remain skeptical about the effectiveness of HMO-based formulas in replicating the full benefits of breastfeeding, which could affect consumer trust in these products.
Market Concentration:
The HMO Children’s Formula Milk Powder market is somewhat concentrated, with a few key players dominating the global market. Large multinational companies such as Nestlé, Danone, Abbott, and Mead Johnson are the primary producers of HMO-based formulas. These companies leverage their established brand recognition, distribution networks, and research capabilities to lead the market.
However, there is room for smaller players to enter the market by offering differentiated products or targeting niche segments, such as organic or region-specific formulas. As the demand for HMO-based formulas grows, it is expected that the market will see increased competition and potentially new entrants.
Downstream Demand Trends:
The downstream demand for HMO Children’s Formula Milk Powder is closely linked to changing consumer preferences. There is a growing trend among parents to choose products that are not only nutritionally balanced but also enhance the health benefits of babies, such as promoting gut health and boosting immunity. As more parents seek premium formulas with added benefits, the demand for HMO-based products is expected to continue growing.
Additionally, with the increasing awareness of health and wellness, consumers are increasingly looking for formulas with clean labels, free from artificial additives and preservatives. There is also a growing interest in formulas that support specific needs, such as sensitive digestion or allergies, driving the demand for specialized HMO-based formulas.
Latest Technologies:
The latest technology in HMO formula production revolves around the advanced fermentation process used to produce oligosaccharides. The fermentation of specific strains of microorganisms to produce HMOs has made it possible to incorporate these beneficial compounds into infant formula at a commercially viable scale.
Furthermore, innovations in packaging, such as the development of air-tight, eco-friendly packaging, have improved product shelf life and convenience. Manufacturers are also exploring ways to enhance the bioavailability of nutrients in the formula to ensure better absorption and digestion for babies.
In conclusion, while the market for HMO Children’s Formula Milk Powder is facing some risks, the opportunities for growth are significant. The increasing demand for infant nutrition solutions that replicate the benefits of breast milk, alongside advancements in technology and product differentiation, will continue to drive the market forward in the coming years.
This report is a detailed and comprehensive analysis for global HMO Children's Formula Milk Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HMO Children's Formula Milk Powder market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Formula Milk Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Formula Milk Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global HMO Children's Formula Milk Powder market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HMO Children's Formula Milk Powder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HMO Children's Formula Milk Powder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso), Yili Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HMO Children's Formula Milk Powder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2'-FL
Others
Market segment by Application
Online Channel
Specialty Store
Supermarket
Other
Major players covered
Abbott
Mead Johnson (Reckitt)
Nestlé
Danone
FrieslandCampina(Friso)
Yili Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HMO Children's Formula Milk Powder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HMO Children's Formula Milk Powder, with price, sales quantity, revenue, and global market share of HMO Children's Formula Milk Powder from 2020 to 2025.
Chapter 3, the HMO Children's Formula Milk Powder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HMO Children's Formula Milk Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HMO Children's Formula Milk Powder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HMO Children's Formula Milk Powder.
Chapter 14 and 15, to describe HMO Children's Formula Milk Powder sales channel, distributors, customers, research findings and conclusion.